Your session is about to expire
← Back to Search
Deep Brain Stimulation and Decision-Making Tasks for Parkinson's Disease (MPPN Trial)
N/A
Recruiting
Led By Simon J Little, MBBS, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years
Awards & highlights
MPPN Trial Summary
This trial will help researchers learn more about how Parkinson's patients make decisions, in hopes of improving treatments for the disease.
Who is the study for?
This trial is for Parkinson's patients who already have a Medtronic Percept PC DBS device implanted. It's not suitable for those with severe cognitive impairments.Check my eligibility
What is being tested?
The study examines how deep brain stimulation (DBS) affects motivation and decision-making in Parkinson's patients, using tasks with the stimulation turned on and off.See study design
What are the potential side effects?
While this study isn't testing a drug, side effects may include discomfort or changes in mood or behavior due to varying levels of brain stimulation during the tasks.
MPPN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of Risky Decisions made with Percept PC DBS stimulation off for Parkinson's Disease Patients
Parkinson Disease
MPPN Trial Design
2Treatment groups
Experimental Treatment
Group I: StimulationExperimental Treatment2 Interventions
Patients will be getting standard clinically acceptable stimulation within already safety validated stimulation ranges through their Medtronic Percept PC device.
Group II: No StimulationExperimental Treatment2 Interventions
Patients will have stimulation turned off through their Medtronic Percept PC device.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,521 Previous Clinical Trials
15,242,194 Total Patients Enrolled
Yale UniversityOTHER
1,865 Previous Clinical Trials
2,742,725 Total Patients Enrolled
Rune LabsUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have Parkinson's Disease.
Research Study Groups:
This trial has the following groups:- Group 1: No Stimulation
- Group 2: Stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Deep Brain Stimulation Patient Testimony for trial: Trial Name: NCT05065151 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger